Spruce Biosciences Inc. (SPRB)
NASDAQ: SPRB
· Real-Time Price · USD
156.61
-2.45 (-1.54%)
At close: Oct 16, 2025, 3:59 PM
155.00
-1.03%
After-hours: Oct 16, 2025, 07:27 PM EDT
-1.54% (1D)
| Bid | 150 |
| Market Cap | 88.18M |
| Revenue (ttm) | 1.3M |
| Net Income (ttm) | -48.34M |
| EPS (ttm) | -86.43 |
| PE Ratio (ttm) | -1.81 |
| Forward PE | -15.46 |
| Analyst | Hold |
| Dividends | n/a |
| Ask | 161 |
| Volume | 116,695 |
| Avg. Volume (20D) | 460,656 |
| Open | 161.10 |
| Previous Close | 159.06 |
| Day's Range | 150.00 - 163.00 |
| 52-Week Range | 7.00 - 3420.00 |
| Beta | 2.48 |
| Ex-Dividend Date | n/a |
About SPRB
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SPRB
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SPRB stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsSpruce Biosciences Inc. is scheduled to release its earnings on
Nov 10, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+1378.46%
Spruce Biosciences shares are trading higher after...
Unlock content with
Pro Subscription
5 months ago
-39.12%
Spruce Biosciences shares are trading lower after the company announced it approved a plan to implement a workforce reduction.
1 week ago · proactiveinvestors.com
Spruce Biosciences shares pop after FDA grants Breakthrough Therapy Designation for rare disease treatmentSpruce Biosciences (NASDAQ:SPRB) shares surged more than 390% to around $43 following news that the US Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BTD) for its tra...
